We conclude that Ang-2 is a predominant regulator of BBB permeability and that targeting the angiopoietin/Tie2 signaling could lead to clinically relevant therapeutics for tightening the BBB in neurological disorders as shown here for ischemic stroke by employing a novel VE-PTP inhibitor. The gene discussed is ANGPT2; the disease is ischemic stroke.